Friederike Holze

16PUBLICATIONS
26CO-AUTHORS
Biologically active moleculesHuman rights and justice issues (excl. law)Psychological methodology, design and analysisPharmaceutical delivery technologiesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 28, 2026
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

|Apr 26, 2026
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

|Dec 26, 2025
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Kurt Stocker, Matthias Hartmann, Yasmin Schmid

|May 26, 2025
Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover Study.

Denis Arikci, Friederike Holze, Lorenz Mueller

|Sep 11, 2024
Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Mihai Avram, Lydia Fortea, Lea Wollner

|Sep 04, 2024
Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

Patrick Vizeli, Erich Studerus, Friederike Holze

Pageof 3

Frequent Collaborators

16 joint publications

Matthias E Liechti

9 joint publications

Patrick Vizeli

6 joint publications

Anne Eckert

5 joint publications

Urs Duthaler